Here we reported an RA patient who developed EBV-associated LPD in immediately after achieving complete remission (CR) by combination of low doses of MTX and TNF-α inhibitor adalimumab (ADA). This evidence concerns the gene TNF and disseminated peritoneal leiomyomatosis.